FDA
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Cortexyme to Present New GAIN Trial Data at AD/PD 2022
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Informatica, C3.ai, and Cortexyme and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Cortexyme Inc. (CRTX) PT Lowered to $5 at Citi
-
-
-
-
-
-
-
Cortexyme Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

